APL93: Timing of CxT and Role of Maintenance

NCT00599937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

576

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Promyelocytic, Acute

Interventions

DRUG: ATRA
DRUG: ATRA and or Chemo as maintenance

Sponsor

Groupe d'etude et de travail sur les leucemies aigues promyelocytaires

Collaborators

[object Object]